NEUROONE MEDICAL TECHNOLOGIES Corp Quarterly Common Stock, Shares, Issued from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
NEUROONE MEDICAL TECHNOLOGIES Corp quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q2 2024.
  • NEUROONE MEDICAL TECHNOLOGIES Corp Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 27.8M shares, a 55.9% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 27.8M +9.98M +55.9% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 26.3M +9.43M +55.9% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 24.8M +8.59M +52.9% Dec 31, 2023 10-Q 2024-02-13
Q3 2023 23.9M +7.71M +47.6% Sep 30, 2023 10-Q 2024-08-14
Q2 2023 17.9M +1.67M +10.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 16.9M +697K +4.3% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 16.2M +50.7K +0.31% Dec 31, 2022 10-Q 2023-02-13
Q3 2022 16.2M +4.21M +35% Sep 30, 2022 10-K 2023-12-15
Q2 2022 16.2M +4.21M +35.2% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 16.2M +4.28M +35.9% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 16.2M -6.9M -29.9% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 12M +4.62M +62.4% Sep 30, 2021 10-K 2022-12-22
Q2 2021 12M -6.26M -34.3% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 11.9M -2.11M -15.1% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 23.1M +9.35M +68.1% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 7.39M -6.1M -45.2% Sep 30, 2020 10-K/A 2022-05-31
Q2 2020 18.2M +4.82M +35.9% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 14M +1.08M +8.33% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 13.7M +3.7M +36.9% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 13.5M +3.84M +39.7% Sep 30, 2019 10-K 2020-12-09
Q2 2019 13.4M +5.4M +67.4% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 12.9M +5.08M +64.6% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 10M +2.17M +27.6% Dec 31, 2018 10-Q 2019-02-14
Q3 2018 9.66M +1.79M +22.8% Sep 30, 2018 10-K 2019-12-20
Q2 2018 8.01M +2.94M +58% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 7.86M +2.79M +55% Mar 31, 2018 10-Q 2018-05-16
Q4 2017 7.86M +2.65M +50.8% Dec 31, 2017 10-KT/A 2019-03-18
Q3 2017 7.86M +2.79M +55% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 5.07M 0 0% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 5.07M 0 0% Mar 31, 2017 10-Q 2017-05-22
Q4 2016 5.22M +144K +2.83% Dec 31, 2016 10-K 2018-04-16
Q3 2016 5.07M 0 0% Sep 30, 2016 10-Q 2016-11-21
Q2 2016 5.07M 0 0% Jun 30, 2016 10-Q 2016-08-19
Q1 2016 5.07M 0 0% Mar 31, 2016 10-Q 2016-05-23
Q4 2015 5.07M 0 0% Dec 31, 2015 10-K 2017-04-17
Q3 2015 5.07M 0 0% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 5.07M 0 0% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 5.07M 0 0% Mar 31, 2015 10-Q 2015-05-20
Q4 2014 5.07M 0 0% Dec 31, 2014 10-K 2016-04-14
Q3 2014 5.07M Sep 30, 2014 10-Q 2014-11-19
Q2 2014 5.07M Jun 30, 2014 10-Q 2014-08-18
Q1 2014 5.07M 0 0% Mar 31, 2014 10-Q 2014-05-20
Q4 2013 5.07M 0 0% Dec 31, 2013 10-K 2015-04-15
Q1 2013 5.07M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 5.07M +573K +12.7% Dec 31, 2012 10-K/A 2014-04-24
Q3 2012 5.07M Sep 30, 2012 10-Q 2012-11-13
Q4 2011 4.5M 0 0% Dec 31, 2011 10-Q 2012-11-13
Q4 2010 4.5M Dec 31, 2010 10-K 2012-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.